title: Methodological remarks concerning the recent meta-analysis on the effect of intravitral bevacizumab in central serous chorioretinopathy.
authors.affiliation: Department of Epidemiology and Biostatistics, University of Athens, Athens, Greece.
authors.forename: T N
authors.initials: TN
authors.lastname: Sergentanis
authors.affiliation: Second Department of Ophthalmology, Ophthalmiatrion Eye Hospital, Athens, Greece.
authors.forename: I P
authors.initials: IP
authors.lastname: Chatziralli
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D056833:Central Serous Chorioretinopathy / Q000188:drug therapy*; D006801:Humans
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized